Statements (63)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
research
|
| gptkbp:collaboratesWith |
gptkb:Bayer
gptkb:Pfizer gptkb:Biogen gptkb:Sanofi gptkb:Wellcome_Sanger_Institute gptkb:European_Bioinformatics_Institute GlaxoSmithKline |
| gptkbp:focusesOn |
drug discovery
target identification target validation |
| gptkbp:foundedIn |
2014
|
| gptkbp:hasResource |
gptkb:Open_Targets_Genetics
gptkb:Open_Targets_Platform gptkb:Open_Targets_Platform_API |
| gptkbp:headquartersLocation |
gptkb:Hinxton,_Cambridgeshire,_UK
|
| https://www.w3.org/2000/01/rdf-schema#label |
Open Targets
|
| gptkbp:mission |
systematic identification and prioritisation of drug targets
|
| gptkbp:usedFor |
chemical biology
clinical trials genomics human genetics proteomics pharmacogenomics pathways electronic health records clinical data epigenetics cell line data functional genomics protein-protein interactions drug information mouse models animal models transcriptomics public databases somatic mutations biomarker data biological pathways literature curation CRISPR screens GWAS studies RNAi screens animal phenotypes cellular assays clinical phenotypes disease ontologies disease phenotypes disease progression data drug repurposing data drug-target interactions eQTL studies expression data gene expression atlases genetic associations literature mining patient registries protein structure data side effect data translational research data |
| gptkbp:website |
https://www.opentargets.org/
|
| gptkbp:bfsParent |
gptkb:European_Bioinformatics_Institute_(EMBL-EBI)
|
| gptkbp:bfsLayer |
5
|